Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study
- 1 December 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (12), 1795-1803
- https://doi.org/10.1016/0277-5379(89)90350-7
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- The interaction of cytostatic drugs with adsorbents in aqueous media. The potential implications for liposome preparationBiochimica et Biophysica Acta (BBA) - Biomembranes, 1985
- Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumour modelBritish Journal of Cancer, 1985
- Photon correlation spectroscopic study of the size distribution of phospholipid vesiclesBiophysical Journal, 1982
- Characterization, toxicity and therapeutic efficacy of adrïamycin encapsulated in liposomesEuropean Journal of Cancer and Clinical Oncology, 1982
- Reporting results of cancer treatmentCancer, 1981
- Colorimetric determination of phospholipids with ammonium ferrothiocyanateAnalytical Biochemistry, 1980
- Evaluation of response criteria in advanced lung cancerCancer, 1979
- Tissue distribution and tumour localization of 99m-technetium-labelled liposomes in cancer patientsBritish Journal of Cancer, 1979
- DRUG-CARRIER POTENTIAL OF LIPOSOMES IN CANCER CHEMOTHERAPYThe Lancet, 1974
- The detection of oxidation in liposome preparationsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1970